KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Accounts Payables (2016 - 2025)

Sarepta Therapeutics has reported Accounts Payables over the past 16 years, most recently at $280.8 million for Q4 2025.

  • For Q4 2025, Accounts Payables rose 30.96% year-over-year to $280.8 million; the TTM value through Dec 2025 reached $280.8 million, up 30.96%, while the annual FY2025 figure was $280.8 million, 30.96% up from the prior year.
  • Accounts Payables for Q4 2025 was $280.8 million at Sarepta Therapeutics, up from $94.0 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $280.8 million in Q4 2025 and troughed at $44.2 million in Q3 2021.
  • A 5-year average of $113.4 million and a median of $101.3 million in 2022 define the central range for Accounts Payables.
  • On a YoY basis, Accounts Payables climbed as much as 188.22% in 2021 and fell as far as 40.74% in 2021.
  • Year by year, Accounts Payables stood at $76.7 million in 2021, then grew by 24.93% to $95.9 million in 2022, then surged by 72.01% to $164.9 million in 2023, then soared by 30.03% to $214.4 million in 2024, then surged by 30.96% to $280.8 million in 2025.
  • Business Quant data shows Accounts Payables for SRPT at $280.8 million in Q4 2025, $94.0 million in Q3 2025, and $136.7 million in Q2 2025.